COVID-19 (coronavirus disease-2019) infection is an extremely prothrombotic state, resulting from a dysregulation of the coagulation cascade. diagnosis of HIT. We also discuss FBL1 potential overdiagnosis of HIT in COVID-19 through 4 cases with false-positive HIT antibodies. strong class=”kwd-title” Keywords: thrombocytopenia, heparin, enoxaparin, heparin-induced thrombocytopenia, COVID-19 Introduction An outbreak of novel coronavirus (2019-nCoV) that began in Wuhan, China, is now a major public health concern worldwide. After the first reported case in the state of Washington, the number of cases in the United States has rapidly increased to over 2?000?000 with more than 100?000 deaths.1 In addition to the typical presentation of respiratory symptoms, hematologic complications have been a significant concern in these patients. Thrombocytopenia has been reported in up to 55% of patients with COVID-19.2 A meta-analysis of 9 studies has shown that platelet counts were significantly lower in those with more severe COVID-19 infection, and thrombocytopenia predicts mortality.2 Heparin-induced thrombocytopenia (HIT) is a differential for thrombocytopenia, especially in the Bisoprolol fumarate intensive care setting. In one review, the authors suggested that clinicians routinely evaluate all COVID-19 patients on heparin for indices of HIT by performing the 4T score.3 We record a complete case of HIT in an individual with critical COVID-19 infection. Also, we explain 4 additional instances which were primarily handled as Strike briefly, until tested never to become accurate Strike later on, predicated on the practical assay. Case Explanation A 63-year-old man without comorbidities offered a week of dried out coughing, myalgias, and diarrhea. On exam, he was afebrile but were in stress, saturating at 89% on space air. Upper body X-ray demonstrated bilateral interstitial opacities. Preliminary laboratory tests exposed an increased C-reactive proteins of 24.49 mg/dL and a higher interleukin-6 degree of 58 pg/mL. Fibrinogen and D-dimer were elevated to 708 mg/dL and 1 also.44 fibrinogen comparative products, respectively. The platelet count number and liver organ function tests had been within normal limitations. He was identified as having COVID-19 by nasopharyngeal reverse-transcriptaseCpolymerase string response. Low-molecular-weight heparin was began for thromboprophylaxis. On day time 2 of entrance, he developed intensifying worsening of dyspnea and was used in the intensive treatment unit (ICU). On day 7, his right lower extremity was noted to be Bisoprolol fumarate swollen. Ultrasound duplex revealed a nonocclusive thrombus within the right common femoral vein. He was started on therapeutic anticoagulation for deep vein thrombosis with enoxaparin, which was switched to unfractionated heparin (UFH) later, due to worsening renal function. On the same day, due to worsening respiratory failure, he was intubated and mechanically ventilated. Between days 11 and 12 of hospitalization, platelet count dropped from 304?000 to 96?000 cells/L. He had a high pretest probability for HIT with a 4T score of 6. HIT antibody testing (anti-PF4/heparin antibody, by enzyme-linked immunosorbent assay) was sent, which returned positive with an optical density (OD) of 1 1.243 units. Heparin drip was discontinued and was switched to argatroban. Unfortunately, he died a day later, following a cardiac arrest. Serotonin release assay (SRA) eventually returned positive, with 49% serotonin release at low UFH dose (0.1 IU/mL) with a reduction to 0% release at high UFH dose (100 IU/mL). This confirmed the diagnosis of HIT. Other Patients With COVID and Possible HIT We encountered 4 additional patients admitted to our ICU with a diagnosis of acute respiratory distress syndrome secondary to COVID-19 infection with thrombocytopenia, and an intermediate to high pretest probability for HIT. Due to a positive platelet factor 4 (PF4) antibody, they were started on an argatroban, pending send out results of OD Bisoprolol fumarate levels and functional assay. However, the SRA was negative. Interestingly, their clinical characteristics (reported in Table 1) were similar to those of our patients with true HIT. Two of these patients had a confirmed deep vein thrombosis, and one with suspected pulmonary embolism. Also, 2 patients met.